Scholars Central

Conference abstract

A preclinical profiling of a promising drug candidate for rheumatoid arthritis

Authors: Gopalan Kutty Nampurath, Jayesh Mudgal, Vasantharaju S Gowdra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A recent report from our lab has claimed the remedial effect of three thiazolidin-4-ones against chemical mediated inflammation. Out of these molecules, [2-(4-chlorophenoxy)-N-(5-methyl-4-oxo-2(pyridin-2-yl) thiazolidin-3-yl) acetamide] (4C), corrected the inflammatory condition through inhibition of the major biomarkers of inflammation and pain such as cytokines (TNF-? and IL-6) and prostaglandin (PGE2) generation. This prompted the evaluation of its antiinflammatory/ antirheumatic effect in an experimental model of arthritis in the present study. After securing ethical clearance, experimental arthritis was induced in Sprague-Dawley rats using sub-plantar injection of complete Freund?s adjuvant (CFA). On Day 14 after CFA injection, animals were randomized and divided into different treatment groups (n=6) based upon the inflammation produced in contra lateral paw (un-injected paw). Treatment with compound 4C inhibited the progression of chronic inflammation and reduced the associated pain sensation in rats. The compound was found effective against polyarthritic condition in rats. In accordance with previous findings, 4C inhibited the generation of pro-inflammatory cytokines (TNF-? and IL-6) and PGE2 in the current experimental model of arthritis. In the earlier work on 4C, we reported the inhibition of COX-2 in vitro and inhibition of PGE2 generation in rat air pouch model. Thus, the mechansisms of anti-inflammatory and analgesic activities of the molecule have been established. In addition, results revealed that compound 4C was safer than diclofenac in terms of side effects such as gastric toxicity, renal toxicity, thrombocytopenia and hypertriglyceridemia that were observed in the current study. The results of study suggest the local and systemic ameliorative effect of oral 4C in arthritis condition.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Gopalan Kutty Nampurath”
  • BylineArticles whose byline prints “Jayesh Mudgal”
  • BylineArticles whose byline prints “Vasantharaju S Gowdra”